← Eichor
Study identifier: NCT02670447 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Early Identification of Patients Presenting a First Psychotic Episode, Non Answering to First Line Support Strategies

Condition: Schizophrenia  ·  Sponsor: Centre Hospitalier Universitaire de Saint Etienne

PhaseN/A
Planned participants80
Who can joinAll sexes, 18 Years to 35 Years
Healthy volunteersNo

About this study

Researchers propose in this project to evaluate predictive factors of non response. It is defined by the lack of symptomatic remission at month 3, for patients presenting a first episode of psychosis. It will be performed on objective markers taken from imagery techniques. The link between evolution of these markers and clinical measures will be studied.

This description comes directly from the study's public registry record.

Talk to the study team

Eric FAKRA, MD PhD  ·  (0)477127885  ·  eric.fakra@chu-st-etienne.fr

Marlène BONNEFOI, Project manager  ·  (0)477120826  ·  marlene.bonnefoi@chu-st-etienne.fr

Always discuss trial participation with your own doctor first.

Locations (5)

Chu Le VinatierBron, FranceNot Yet Recruiting
Chu Clermont-FerrandClermont-Ferrand, FranceNot Yet Recruiting
Chu GrenobleGrenoble, FranceNot Yet Recruiting
HÔPITAL Edouard HerriotLyon, FranceNot Yet Recruiting
Chu Saint EtienneSaint-Etienne, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02670447